Public Sector Pension Investment Board Raises Stock Position in The Chemours Company $CC

Public Sector Pension Investment Board boosted its stake in shares of The Chemours Company (NYSE:CC) by 14.4% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 583,947 shares of the specialty chemicals company’s stock after purchasing an additional 73,635 shares during the period. Public Sector Pension Investment Board owned approximately 0.39% of Chemours worth $9,250,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. MTM Investment Management LLC purchased a new stake in shares of Chemours in the second quarter worth about $27,000. Evelyn Partners Asset Management Ltd acquired a new position in Chemours in the second quarter valued at approximately $37,000. FNY Investment Advisers LLC grew its stake in shares of Chemours by 100.0% during the 2nd quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock worth $45,000 after purchasing an additional 2,000 shares during the period. CWM LLC increased its holdings in shares of Chemours by 34.7% during the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $49,000 after purchasing an additional 1,104 shares in the last quarter. Finally, Hantz Financial Services Inc. lifted its stake in shares of Chemours by 334.2% in the 3rd quarter. Hantz Financial Services Inc. now owns 4,329 shares of the specialty chemicals company’s stock valued at $69,000 after purchasing an additional 3,332 shares during the period. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Wall Street Analysts Forecast Growth

CC has been the topic of several analyst reports. Truist Financial raised their price target on shares of Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a research report on Wednesday, January 21st. Royal Bank Of Canada restated an “outperform” rating and issued a $18.00 price target on shares of Chemours in a research note on Friday, January 16th. UBS Group dropped their price objective on Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th. Weiss Ratings reiterated a “sell (d)” rating on shares of Chemours in a research report on Wednesday, January 21st. Finally, BMO Capital Markets restated an “outperform” rating and set a $20.00 price objective on shares of Chemours in a research report on Monday, January 19th. Five research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $16.67.

Chemours Stock Up 0.3%

CC stock opened at $20.48 on Tuesday. The Chemours Company has a 12 month low of $9.13 and a 12 month high of $21.85. The company has a market cap of $3.07 billion, a price-to-earnings ratio of -9.23 and a beta of 1.63. The company has a current ratio of 1.71, a quick ratio of 0.88 and a debt-to-equity ratio of 13.66. The firm has a 50-day moving average of $14.69 and a two-hundred day moving average of $14.25.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.